Tosufloxacina (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Tosufloxacina" in Italian language version.

refsWebsite

Global rank Italian rank

25nih.gov

4^th place

9^th place

11asm.org

3,555^th place

2,382^nd place

1archive.org

6^th place

8^th place

archive.org

Nix DE, Watson WA, Lener ME, Frost RW, Krol G, Goldstein H, Lettieri J, Schentag JJ, Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin, in Clinical Pharmacology and Therapeutics, vol. 46, n. 6, dicembre 1989, pp. 700–5, PMID 2598571.

asm.org

aac.asm.org

Tanaka M, Sato K, Kimura Y, Hayakawa I, Osada Y, Nishino T, Inhibition by quinolones of DNA gyrase from Staphylococcus aureus, in Antimicrobial Agents and Chemotherapy, vol. 35, n. 7, luglio 1991, pp. 1489–91, PMC 245197, PMID 1656864. URL consultato il 2 novembre 2014.
Wolfson JS, Hooper DC, The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro, in Antimicrob. Agents Chemother., vol. 28, n. 4, ottobre 1985, pp. 581–6, PMC 180310, PMID 3000292. URL consultato il 2 novembre 2014.
Yoshida H, Nakamura M, Bogaki M, Ito H, Kojima T, Hattori H, Nakamura S, Mechanism of action of quinolones against Escherichia coli DNA gyrase, in Antimicrob. Agents Chemother., vol. 37, n. 4, aprile 1993, pp. 839–45, PMC 187778, PMID 8388200. URL consultato il 24 settembre 2014.
Maeda H, Fujii A, Nakata K, Arakawa S, Kamidono S, In vitro activities of T-3262, NY-198, fleroxacin (AM-833; RO 23-6240), and other new quinolone agents against clinically isolated Chlamydia trachomatis strains, in Antimicrobial Agents and Chemotherapy, vol. 32, n. 7, luglio 1988, pp. 1080–1, PMC 172348, PMID 2847640. URL consultato il 1º novembre 2014.
Fujimaki K, Noumi T, Saikawa I, Inoue M, Mitsuhashi S, In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone, in Antimicrobial Agents and Chemotherapy, vol. 32, n. 6, giugno 1988, pp. 827–33, PMC 172290, PMID 2843082. URL consultato il 1º novembre 2014.
Arguedas AG, Akaniro JC, Stutman HR, Marks MI, In vitro activity of tosufloxacin, a new quinolone, against respiratory pathogens derived from cystic fibrosis sputum, in Antimicrobial Agents and Chemotherapy, vol. 34, n. 11, novembre 1990, pp. 2223–7, PMC 172026, PMID 2073112. URL consultato il 2 novembre 2014.
Barry AL, Fuchs PC, In vitro activities of sparfloxacin, tosufloxacin, ciprofloxacin, and fleroxacin, in Antimicrobial Agents and Chemotherapy, vol. 35, n. 5, maggio 1991, pp. 955–60, PMC 245135, PMID 1906696. URL consultato il 2 novembre 2014.
Lazzaroni M, Imbimbo BP, Bargiggia S, Sangaletti O, Dal Bo L, Broccali G, Bianchi Porro G, Effects of magnesium-aluminum hydroxide antacid on absorption of rufloxacin, in Antimicrobial Agents and Chemotherapy, vol. 37, n. 10, ottobre 1993, pp. 2212–6, PMC 192252, PMID 8257146. URL consultato il 1º novembre 2014.
Shimada J, Shiba K, Oguma T, Miwa H, Yoshimura Y, Nishikawa T, Okabayashi Y, Kitagawa T, Yamamoto S, Effect of antacid on absorption of the quinolone lomefloxacin, in Antimicrobial Agents and Chemotherapy, vol. 36, n. 6, giugno 1992, pp. 1219–24, PMC 190321, PMID 1329615. URL consultato il 1º novembre 2014.
Minami R, Nakamura C, Inotsume N, Nakano M, Effects of aluminum hydroxide and famotidine on bioavailability of tosufloxacin in healthy volunteers, in Antimicrobial Agents and Chemotherapy, vol. 42, n. 2, febbraio 1998, pp. 453–5, PMC 105434, PMID 9527806. URL consultato il 1º novembre 2014.
Segreti J, Hirsch DJ, Harris AA, Kapell KS, Orbach H, Kessler HA, In vitro activity of tosufloxacin (A-61827; T-3262) against selected genital pathogens, in Antimicrobial Agents and Chemotherapy, vol. 34, n. 6, giugno 1990, pp. 971–3, PMC 171740, PMID 2118330. URL consultato il 2 novembre 2014.

nih.gov

ncbi.nlm.nih.gov

Tanaka M, Sato K, Kimura Y, Hayakawa I, Osada Y, Nishino T, Inhibition by quinolones of DNA gyrase from Staphylococcus aureus, in Antimicrobial Agents and Chemotherapy, vol. 35, n. 7, luglio 1991, pp. 1489–91, PMC 245197, PMID 1656864. URL consultato il 2 novembre 2014.
Wolfson JS, Hooper DC, The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro, in Antimicrob. Agents Chemother., vol. 28, n. 4, ottobre 1985, pp. 581–6, PMC 180310, PMID 3000292. URL consultato il 2 novembre 2014.
Yoshida H, Nakamura M, Bogaki M, Ito H, Kojima T, Hattori H, Nakamura S, Mechanism of action of quinolones against Escherichia coli DNA gyrase, in Antimicrob. Agents Chemother., vol. 37, n. 4, aprile 1993, pp. 839–45, PMC 187778, PMID 8388200. URL consultato il 24 settembre 2014.
Aubert G, Pozzetto B, Dorche G, [In vitro bactericidal effect of temafloxacin and tosufloxacin against streptococci], in Pathologie-biologie, vol. 39, n. 10, dicembre 1991, pp. 1002–5, PMID 1666667.
Maeda H, Fujii A, Nakata K, Arakawa S, Kamidono S, In vitro activities of T-3262, NY-198, fleroxacin (AM-833; RO 23-6240), and other new quinolone agents against clinically isolated Chlamydia trachomatis strains, in Antimicrobial Agents and Chemotherapy, vol. 32, n. 7, luglio 1988, pp. 1080–1, PMC 172348, PMID 2847640. URL consultato il 1º novembre 2014.
Fujimaki K, Noumi T, Saikawa I, Inoue M, Mitsuhashi S, In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone, in Antimicrobial Agents and Chemotherapy, vol. 32, n. 6, giugno 1988, pp. 827–33, PMC 172290, PMID 2843082. URL consultato il 1º novembre 2014.
Arguedas AG, Akaniro JC, Stutman HR, Marks MI, In vitro activity of tosufloxacin, a new quinolone, against respiratory pathogens derived from cystic fibrosis sputum, in Antimicrobial Agents and Chemotherapy, vol. 34, n. 11, novembre 1990, pp. 2223–7, PMC 172026, PMID 2073112. URL consultato il 2 novembre 2014.
Barry AL, Fuchs PC, In vitro activities of sparfloxacin, tosufloxacin, ciprofloxacin, and fleroxacin, in Antimicrobial Agents and Chemotherapy, vol. 35, n. 5, maggio 1991, pp. 955–60, PMC 245135, PMID 1906696. URL consultato il 2 novembre 2014.
Granneman GR, Stephan U, Birner B, Sörgel F, Mukherjee D, Effect of antacid medication on the pharmacokinetics of temafloxacin, in Clinical Pharmacokinetics, 22 Suppl 1, 1992, pp. 83–9, PMID 1319875.
Nix DE, Watson WA, Lener ME, Frost RW, Krol G, Goldstein H, Lettieri J, Schentag JJ, Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin, in Clinical Pharmacology and Therapeutics, vol. 46, n. 6, dicembre 1989, pp. 700–5, PMID 2598571.
Lazzaroni M, Imbimbo BP, Bargiggia S, Sangaletti O, Dal Bo L, Broccali G, Bianchi Porro G, Effects of magnesium-aluminum hydroxide antacid on absorption of rufloxacin, in Antimicrobial Agents and Chemotherapy, vol. 37, n. 10, ottobre 1993, pp. 2212–6, PMC 192252, PMID 8257146. URL consultato il 1º novembre 2014.
Shimada J, Shiba K, Oguma T, Miwa H, Yoshimura Y, Nishikawa T, Okabayashi Y, Kitagawa T, Yamamoto S, Effect of antacid on absorption of the quinolone lomefloxacin, in Antimicrobial Agents and Chemotherapy, vol. 36, n. 6, giugno 1992, pp. 1219–24, PMC 190321, PMID 1329615. URL consultato il 1º novembre 2014.
Nakano M, Yamamoto M, Arita T, Interactions of aluminum, magnesium, and calcium ions with nalidixic acid, in Chemical & Pharmaceutical Bulletin, vol. 26, n. 5, maggio 1978, pp. 1505–10, PMID 668025.
Minami R, Nakamura C, Inotsume N, Nakano M, Effects of aluminum hydroxide and famotidine on bioavailability of tosufloxacin in healthy volunteers, in Antimicrobial Agents and Chemotherapy, vol. 42, n. 2, febbraio 1998, pp. 453–5, PMC 105434, PMID 9527806. URL consultato il 1º novembre 2014.
Aoki T, Matsubara Y, Sagara H, Shimizu N, Tomizawa I, Takizawa Y, Nitia Y, Seo T, Kamimura M, Kanehisa N, [Clinical trial of T-3262 (Tosufloxacin tosilate) on Salmonella enteritis, and fecal drug concentration and change in the fecal microflora in the acute diarrheal patients. Japan Research Committee of T-3262, Research Group for Acute Infectious Enteritis], in Kansenshōgaku Zasshi. The Journal of the Japanese Association for Infectious Diseases, vol. 63, n. 7, luglio 1989, pp. 659–75, PMID 2693543.
Ohnishi K, Murata M, Ajima I, Saku K, Nakamura A, [Treatment of typhoid fever with tosufloxacin], in Kansenshōgaku Zasshi. The Journal of the Japanese Association for Infectious Diseases, vol. 66, n. 9, settembre 1992, pp. 1295–6, PMID 1431392.
Suzuki K, Nagata Y, [Clinical efficacy of T-3262, a new quinolone compound, on urinary tract infection in 1988], in Hinyokika Kiyo. Acta Urologica Japonica, vol. 35, n. 4, aprile 1989, pp. 717–26, PMID 2735274.
Uchibayashi T, Hisazumi H, Kanayama J, Kumano K, Diffusion of tosufloxacin into prostatic tissue, in Chemotherapy, vol. 38, n. 3, 1992, pp. 150–4, PMID 1380905.
Yoshida K, Kobayashi N, Saitoh H, Negishi T, Yamada T, Watanabe T, Kawakami S, Tari K, Satake I, Ozawa K, [Clinical efficacy of tosufloxacin on the patients with urinary tract infections], in Hinyokika Kiyo. Acta Urologica Japonica, vol. 38, n. 1, gennaio 1992, pp. 129–34, PMID 1546562.
Fukushima S, Moriyama M, Miyamoto H, Hosaka M, Kubota Y, Kinoshita Y, Noguchi K, Shuin T, Noguchi S, Yoshimura S, [Clinical studies on tosufloxacin (TFLX) in urology], in Hinyokika Kiyo. Acta Urologica Japonica, vol. 38, n. 4, aprile 1992, pp. 501–6, PMID 1529827.
Ikeuchi T, Kawamura N, Suzuki K, Onodera S, Osada T, Hirano A, Satomi Y, Yoshimura S, Yamamoto Y, [Clinical studies of tosufloxacin on chronic bacterial prostatitis], in Hinyokika Kiyo. Acta Urologica Japonica, vol. 39, n. 7, luglio 1993, pp. 673–8, PMID 8362691.
Sakurai M, Sugimura Y, Arima K, Kawamura J, Saitou K, Tajima K, Nakano S, Satani H, Nagano M, Hoshina A, [Study on clinical effects of tosufloxacin (TFLX) and the long-term low dose therapy for the prophylaxis of recurrent urinary tract infection], in Hinyokika Kiyo. Acta Urologica Japonica, vol. 40, n. 3, marzo 1994, pp. 279–84, PMID 8178752.
Segreti J, Hirsch DJ, Harris AA, Kapell KS, Orbach H, Kessler HA, In vitro activity of tosufloxacin (A-61827; T-3262) against selected genital pathogens, in Antimicrobial Agents and Chemotherapy, vol. 34, n. 6, giugno 1990, pp. 971–3, PMC 171740, PMID 2118330. URL consultato il 2 novembre 2014.
Sugata F, Ohguri S, Takamura Y, Tominaga S, Iwamura K, Yamada T, Shibata H, Yamada N, Okabe K, Kato Y, [Biliary excretion and clinical efficacy of T-3262 (tosufloxacin tosilate) administered in the treatment of cholecystitis], in The Japanese Journal of Antibiotics, vol. 42, n. 9, settembre 1989, pp. 1873–81, PMID 2810750.
Yamashiro Y, Nunome M, Takahata M, Yasuda T, [Penetration into bone and joint tissues of rabbits and in vitro antibacterial activity of tosufloxacin], in The Japanese Journal of Antibiotics, vol. 46, n. 1, gennaio 1993, pp. 31–5, PMID 8384277.